Education and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Ailsa Budden
Advertisement
Senior Director, Global Medical Education—Oncology, Eli Lilly
Articles by Ailsa Budden
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Artisan Partners’ Director Calls for Novartis Board Shake-Up
2
340B Under Pressure: Inside Pharma's Push for Greater Clarity
3
Kura Oncology Spins Out Caspian Therapeutics With $50 Million to Test Menin Inhibition as a Disease-Modifying Approach to Diabetes
4
The Agentic AI Revolution in Biopharma
5